Dr. Amirrtha Srikanthan is an assistant professor in the Department of Medicine at the University of Ottawa, a clinician investigator in the Cancer Therapeutics Program at the Ottawa Hospital Research Institute, and an academic medical oncologist specializing in adolescent and young adult (AYA) oncology, breast cancer, and sarcoma in the Division of Medical Oncology at the Ottawa Hospital. She is currently the Medical Lead of the Wellness Beyond Cancer Program at the Ottawa Hospital and also serves as national chair of the Royal College Area of Focused Competency in AYA Oncology.
Dr. Sharon McGee is a staff medical oncologist at the Ottawa Hospital, a clinician investigator at the Ottawa Hospital Research Institute, and an assistant professor of medicine at the University of Ottawa. She specializes in the management of breast and skin cancers. Her specific areas of interest include pragmatic clinical trials, the management of side effects/toxicities related to cancer treatment, and patient support.
Dr. Moira Rushton is a medical oncologist based in Ottawa, Ontario, a senior investigator with the Canadian Cancer Trials Group in the IND program, and an adjunct assistant professor in the Faculty of Health Sciences at Queen’s University. She completed a master’s degree in Public Health at the University of California Berkeley (class of 2021) as well as having spent time as a research fellow at CCTG, working in both IND and phase 3 trials in 2019–2020. Her area of clinical focus is breast cancer.
